Journal of the Chinese Medical Association
Volume 70, Issue 5 , Pages 218-221, May 2007

Fertility Preservation with Treatment of Immature Teratoma of the Ovary

  • Chia-Hui Chen

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • ,
  • Ming-Jie Yang

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • ,
  • Ming-Huei Cheng

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • ,
  • Ming-Shyen Yen

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • ,
  • Chiung-Ru Lai

      Affiliations

    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • Department of Pathology, Taipei Veterans General Hospital, Taipei, Taiwan, R.O.C.
    • ,
  • Peng-Hui Wang

      Affiliations

    • Department of Obstetrics and Gynecology, Taipei, Taiwan, R.O.C.
    • National Yang-Ming University School of Medicine, Taipei, Taiwan, R.O.C.
    • Corresponding Author InformationCorrespondence to: Dr Peng-Hui Wang, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital, 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan, R.O.C.

Received 19 September 2006; accepted 26 March 2007.

Article Outline

Fertility preservation for a patient with advanced immature teratoma of the ovary is reported. The patient, a 29-year-old woman, delivered a healthy baby after having had ovarian immature teratoma, grade 3, uncertain stage, at 13 years of age. She was initially treated with unilateral salpingo-oophorectomy and a contralateral wedge resection for tumor invasion, followed by a 6-course cisplatin + vinblastine + bleomycin regimen, a second operation, and an additional 6-course etoposide and cisplatin regimen with complete remission. The patient delivered a healthy baby 16 years after the initial treatment. Based on this successful case, intensive fertility-preserving surgery followed by chemotherapy, even in advanced-stage immature teratomas of the ovary, may be effective in preserving the reproductive function of women with malignant immature teratomas of the ovary.

Key Words:  fertility-preserving surgery , immature teratoma , ovary

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Lu KH , Gershenson DM . Update on the management of ovarian germ cell tumors . J Reprod Med . 2005;50:417–425
  2. Wang PH, Yuan CC, Chao HT, Yu KJ, Hung JH, Yang ML, et al  Ovarian surgery during pregnancy and puer-perium: twelve-year experience at Veterans General Hospital – Taipei . J Chin Med Assoc . 1998;61:324–331
  3. Yuan CC , Ng HT , Chou MM , Chang MC , Liu HC . Malignant germ cell tumors of ovary: a 15-year survey at VGH . J Chin Med Assoc . 1987;39:14–21
  4. Wu RT, Torng PL, Chang DY, Chen CK, Chen RJ, Lin MC, et al. Mature cystic teratoma of the ovary: a clinicopatho-logical study of 283 cases . J Chin Med Assoc . 1996;58:269–274
  5. Gershenson DM . Update on malignant ovarian germ cell tumors . Cancer . 1993;71:1581–1590
  6. El-Lamie IK , Shehata NA , Abou-Loz SK , El-Lamie KI . Conservative surgical management of malignant ovarian germ cell tumors: the experience of the Gynecologic Oncology Unit at Ain Shams University . Eur J Gynaecol Oncol . 2000;21:605–609
  7. Bakri YN , Ezzat A , Zahrani AD . Malignant germ cell tumors of the ovary: pregnancy considerations . Eur J Obstet Gynecol Reprod Biol . 2000;90:87–91
  8. Lee RB , Kelly J , Elg SA , Benson WL . Pregnancy following conservative surgery and adjunctive chemotherapy for stage III immature teratoma of the ovary . Obstet Gynecol . 1989;73:853–855
  9. O'Connor DM , Norris HJ . The influence of grade on the outcome of stage I ovarian immature (malignant) teratomas and the reproducibility of grading . Int J Gynecol Pathol . 1994;13:283–289
  10. Norris HJ , Zirkin HJ , Benson WL . Immature (malignant) ter-atoma of the ovary: a clinical and pathologic study of 58 cases . Cancer . 1976;37:2359–2372
  11. Gershenson DM . The obsolescence of second-look laparotomy in the management of malignant ovarian germ cell tumors . Gynecol Oncol . 1994;52:283–285
  12. Smith JP , Rutledge FN . Advances in chemotherapy for gynecologic cancer . Cancer . 1975;36:669–674
  13. Einhorn LH , Donohue J . Cis-diamminedichloroplatinum, vin-blastine, and bleomycin combination chemotherapy in disseminated testicular cancer . Ann Intern Med . 1977;87:293–298
  14. Slayton RE , Park RC , Silverberg SG , Shingleton H , Creasman WT , Blessing JA . Vincristine, dactinomycin, and cyclophos-phamide in the treatment of malignant germ cell tumors of the ovary: a Gynecologic Oncology Group study (a final report) . Cancer . 1985;56:243–248
  15. Culine S, Kattan J, Lhomme C, Duvillard P, Michel G, Castaigne D, et al  A phase II study of high-dose cis-platin, vinblastine, bleomycin, and etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary . Gynecol Oncol . 1994;54:47–53
  16. Segelov E, Campbell J, Ng M, Tattersall M, Rome R, Free K, et al  Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience . J Clin Oncol . 1994;12:378–384
  17. Williams S , Blessing JA , Liao SY , Ball H , Hanjani P . Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group . J Clin Oncol . 1994;12:701–706
  18. Gershenson DM , Morris M , Burke TW , Levenback C , Matthews CM , Wharton JT . Treatment of poor-prognosis sex cord-stromal tumors of the ovary with the combination of bleomycin, etopo-side, and cisplatin . Obstet Gynecol . 1996;87:527–531
  19. Homesley HD , Bundy BN , Hurteau JA , Roth LM . Bleomycin, etoposide, and cisplatin combination therapy of ovarian granu-losa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study . Gynecol Oncol . 1999;72:131–137
  20. Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Sokal M, et al  The United Kingdom Children's Cancer Study Group's second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity . J Clin Oncol . 2000;18:3809–3818
  21. Dimopoulos MA, Papadimitriou C, Hamilos G, Efstathiou E, Vlahos G, Rodolakis A, et al  Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study . Gynecol Oncol . 2004;95:695–700
  22. Rogers PC, Olson TA, Cullen JW, Billmire DF, Marina N, Rescorla F, et al  Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: pediatric intergroup study – Pediatric Oncology Group 9048 and Children's Cancer Group 8891 . J Clin Oncol . 2004;22:3563–3569
  23. Cushing B, Giller R, Cullen JW, Marina NM, Lauer SJ, Olson TA, et al  Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study – Pediatric Oncology Group 9049 and Children's Cancer Group 8882 . J Clin Oncol . 2004;22:2691–2700
  24. Williams SD , Blessing JA , DiSaia PJ , Major FJ , Ball HG , Liao SY . Second-look laparotomy in ovarian germ cell tumors: the gynecologic oncology group experience . Gynecol Oncol . 1994;52:287–291
  25. Culine S , Lhomme C , Michel G , Leclere J , Duvillard P , Droz JP . Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institute Gustave Roussy . J Surg Oncol . 1996;62:40–45
  26. Whitworth A . New options expand possibilities for fertility preservation in cancer patients . J Natl Cancer Inst . 2006;98:1358–1360
  27. Chao HT , Wang PH , Yuan CC , Lee WL . Successful pregnancy in a woman with acute myeloid leukemia treated with high-dose whole-body irradiation . J Reprod Med . 1999;43:703–706
  28. Seli E , Tangir J . Fertility preservation options for female patients with malignancies . Curr Opin Obstet Gynecol . 2005;17:299–308
  29. Falcone T , Bedaiwy MA . Fertility preservation and pregnancy outcome after malignancy . Curr Opin Obstet Gynecol . 2005;17:21–26
  30. Gershenson DM . Fertility-sparing surgery for malignancies in women . J Natl Cancer Inst . 2005;34:43–47
  31. Gershenson DM . Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors . J Clin Oncol . 1988;6:270–275
  32. Brewer M , Gershenson DM , Herzog CE , Mitchell MF , Silva EG , Wharton JT . Outcome and reproductive function after chemotherapy for ovarian dysgerminoma . J Clin Oncol . 1999;17:2670–2675
  33. Low JJH , Perrin LC , Crandon AJ , Hacker NF . Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors . Cancer . 2000;89:391–398
  34. Zanetta G, Bonazzi C, Cantu M, Binidagger S, Locatelli A, Bratina G, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors . J Clin Oncol . 2001;19:1015–1020
  35. Tangir J , Zelterman D , Ma W , Schwartz PE . Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary . Obstet Gynecol . 2003;101:251–257

PII: S1726-4901(09)70362-4

doi:10.1016/S1726-4901(09)70362-4

Journal of the Chinese Medical Association
Volume 70, Issue 5 , Pages 218-221, May 2007

Article Tools